Huddersfield research predicted anti-COVID steroid benefits

Press/Media: Research

Description

Huddersfield researchers publish study that found that dexamethasone could reduce death rates in hospitalised COVID-19 patients early in the pandemic.

A study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroids such as dexamethasone on hospitalised COVID-19 patients with acute respiratory distress syndrome (ARDS) who were on respiratory support.

By mid-April they had found that the proportion of COVID-19 patients who died in the steroid group was significantly lower compared to those who did not receive corticosteroids, at 28 per cent vs. 69 per cent. Their research has now been published in the Expert Review of Respiratory Medicine following a lengthy period of scrutiny and peer review.

The Huddersfield academics’ work highlights the issues involved in scrutinising scientific evidence, as well as costs involved in research and the UK’s preference for evidence-based practice. Oxford University’s RECOVERY trial came to similar conclusions as the Huddersfield researchers in mid-June, leading to the UK government’s decision that dexamethasone could be made available to patients, a move being followed around the world.

Subject

CoViD-19 and role of steroids in reducing motality

Period17 Aug 2020 → 22 Aug 2020

Media coverage

13

Media coverage

  • TitleCould thousands of lives lost to COVID-19 have been saved had the findings of this study been implemented?​
    Media name/outletDailyHunt
    CountryIndia
    Date22/08/20
    DescriptionIn mid-April, when the spread of COVID-19 pandemic beyond China's borders hadn't yet led to a big loss of human lives, a study showed that steroid use could save many people killed by the novel coronavirus.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan, researchers at the University of Huddersfield, England, found that using corticosteroids such as dexamethasone lowered the death rate due to acute respiratory distress syndrome (ARDS) associated with severe COVID-19 cases.

    The two scientists analysed data related to COVID-19 patients who got severely ill and eventually lost the battle to it. These people were among those who were treated with corticosteroids. They found that 28 percent of those who were given this type of steroids died, but 69 percent of those in groups of patients who were not given corticosteroids also died. Their research has now been published in the Expert Review of Respiratory Medicine Journal after a long peer-review.

    This conclusion by Huddersfield scientists is significant since the same results came to light in the famous 'RECOVERY' trials at Oxford University, two months after their study, following which, the United Kingdom government approved the use of dexamethasone for treating coronavirus patients. The rest of the world soon followed suit.

    However, according to data from Worldometer, over 300,000 people had lost their lives due to COVID-19 between mid-April and mid-June. This suggests that if the analysis of Dr Hamid and Dr Syed had been considered in April itself, perhaps many lives could have been saved across the world.
    URLhttps://m.dailyhunt.in/news/india/english/first+post-epaper-fposteng/could+thousands+of+lives+lost+to+covid+19+have+been+saved+had+the+findings+of+this+study+been+implemented-newsid-n208530944
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleCould thousands of lives lost to COVID-19 have been saved had the findings of this study been implemented?​
    Media name/outletFirstPost
    CountryIndia
    Date22/08/20
    DescriptionDr Hamid Merchant and Dr Syed Shahzad Hasan, researchers at the University of Huddersfield, England, found that using corticosteroids such as dexamethasone lowered the death rate due to acute respiratory distress syndrome (ARDS) associated with severe COVID-19 cases.
    URLhttps://www.firstpost.com/india/covid-19-deaths-could-thousands-of-lives-lost-been-saved-had-the-findings-of-this-study-been-implemented-8741031.html
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleCould thousands of lives lost to COVID-19 have been saved had the findings of this study been implemented?​
    Media name/outletYahoo News
    CountryUnited Kingdom
    Date22/08/20
    DescriptionIn mid-April, when the spread of COVID-19 pandemic beyond China's borders hadn't yet led to a big loss of human lives, a study showed that steroid use could save many people killed by the novel coronavirus.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan, researchers at the University of Huddersfield, England, found that using corticosteroids such as dexamethasone lowered the death rate due to acute respiratory distress syndrome (ARDS) associated with severe COVID-19 cases.
    URLhttps://in.news.yahoo.com/could-thousands-lives-lost-covid-094716494.html?guccounter=1
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleCould thousands of lives lost to COVID-19 have been saved had the findings of this study been implemented?​
    Media name/outletMSN News
    CountryUnited Kingdom
    Date22/08/20
    DescriptionIn mid-April, when the spread of COVID-19 pandemic beyond China's borders hadn’t yet led to a big loss of human lives, a study showed that steroid use could save many people killed by the novel coronavirus.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan, researchers at the University of Huddersfield, England, found that using corticosteroids such as dexamethasone lowered the death rate due to acute respiratory distress syndrome (ARDS) associated with severe COVID-19 cases.
    URLhttps://www.msn.com/en-in/health/nutrition/could-thousands-of-lives-lost-to-covid-19-have-been-saved-had-the-findings-of-this-study-been-implemented%e2%80%8b/ar-BB18fCQS
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleResearch predicted anti-COVID steroid benefits
    Media name/outletDrug Discovery World
    CountryUnited Kingdom
    Date19/08/20
    DescriptionA study early in the global coronavirus pandemic evidenced the benefits of using steroids to combat COVID-19

    According to researchers at the UK’s University of Huddersfield, a study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives,

    Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroid such as dexamethasone on hospitalised COVID-19 patients with acute respiratory distress syndrome (ARDS) on respiratory support.

    By mid-April they had found that the proportion of COVID-19 patients who died in the steroid group was significantly lower compared with those who did not receive corticosteroids, at 28% compared to 69%. Their research has now been published in the Expert Review of Respiratory Medicine following a lengthy period of scrutiny and peer review.
    URLhttps://www.ddw-online.com/research-predicted-anti-covid-steroid-benefits-3238-202008/
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHuddersfield research predicted anti-COVID steroid benefits
    Media name/outletEureka Alert
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.
    URLhttps://www.eurekalert.org/pub_releases/2020-08/uoh-hrp081820.php
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHistoric study that evidenced the benefits of anti-COVID steroids could have saved lives
    Media name/outletNews Medical
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroid such as dexamethasone on hospitalized COVID-19 patients with acute respiratory distress syndrome (ARDS) on respiratory support.
    URLhttps://www.news-medical.net/news/20200818/Historic-study-that-evidenced-the-benefits-of-anti-COVID-Steroids-could-have-saved-lives.aspx
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleCould Steroids Be Used To Combat COVID-19 in Severely Ill Patients?
    Media name/outletTechnology Networks
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.
    URLhttps://www.technologynetworks.com/tn/news/could-steroids-be-used-to-combat-covid-19-in-severely-ill-patients-338733
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHuddersfield research predicted anti-COVID steroid benefits
    Media name/outletAlpha Galileo
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroid such as dexamethasone on hospitalised COVID-19 patients with acute respiratory distress syndrome (ARDS) on respiratory support. By mid-April they had found that the proportion of COVID-19 patients who died in the steroid group was significantly lower compared to those who did not receive corticosteroids, at 28 percent compared to 69 percent. Their research has now been published in the Expert Review of Respiratory Medicine following a lengthy period of scrutiny and peer review.
    URLhttps://www.alphagalileo.org/en-gb/Item-Display/ItemId/196280?returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/196280
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleDexamethasone could reduce death rates in hospitalised COVID-19 patients
    Media name/outletMedical Xpress
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.
    URLhttps://medicalxpress.com/news/2020-08-dexamethasone-death-hospitalised-covid-patients.html
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHuddersfield research predicted anti-COVID steroid benefits
    Media name/outletScience Codex
    CountryUnited Kingdom
    Date18/08/20
    DescriptionA study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroid such as dexamethasone on hospitalised COVID-19 patients with acute respiratory distress syndrome (ARDS) on respiratory support. By mid-April they had found that the proportion of COVID-19 patients who died in the steroid group was significantly lower compared to those who did not receive corticosteroids, at 28 per cent compared to 69 per cent. Their research has now been published in the Expert Review of Respiratory Medicine following a lengthy period of scrutiny and peer review.
    URLhttps://www.sciencecodex.com/huddersfield-research-predicted-anti-covid-steroid-benefits-654418
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHuddersfield research predicted anti-COVID steroid benefits
    Media name/outletScience Magazine
    CountryUnited Kingdom
    Date18/08/20
    DescriptionHuddersfield researchers publish study that found that dexamethasone could reduce death rates in hospitalised COVID-19 patients early in the pandemic.
    URLhttps://scienmag.com/huddersfield-research-predicted-anti-covid-steroid-benefits/
    PersonsHamid Merchant, Syed Shahzad Hasan
  • TitleHuddersfield research predicted anti-COVID steroid benefits
    Media name/outletUniversity News
    CountryUnited Kingdom
    Date17/08/20
    DescriptionHuddersfield researchers publish study that found that dexamethasone could reduce death rates in hospitalised COVID-19 patients early in the pandemic.

    A study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

    Dr Hamid Merchant and Dr Syed Shahzad Hasan assessed the results of using corticosteroids such as dexamethasone on hospitalised COVID-19 patients with acute respiratory distress syndrome (ARDS) who were on respiratory support.

    By mid-April they had found that the proportion of COVID-19 patients who died in the steroid group was significantly lower compared to those who did not receive corticosteroids, at 28 per cent vs. 69 per cent. Their research has now been published in the Expert Review of Respiratory Medicine following a lengthy period of scrutiny and peer review.

    The Huddersfield academics’ work highlights the issues involved in scrutinising scientific evidence, as well as costs involved in research and the UK’s preference for evidence-based practice. Oxford University’s RECOVERY trial came to similar conclusions as the Huddersfield researchers in mid-June, leading to the UK government’s decision that dexamethasone could be made available to patients, a move being followed around the world.
    URLhttps://www.hud.ac.uk/news/2020/august/huddersfield-research-covid-steroid-benefits/
    PersonsHamid Merchant, Syed Shahzad Hasan